IMS Health was accused of “anticompetitive actions” over pharmaceutical data markets in an antitrust complaint filed by its top competitor Symphony Health Solutions, according to the Courthouse News Service on Friday. IMS Health, based in Pennsylvania, supplies health data to pharmaceutical and biotech companies to generate drug prescription and consumption predictions. Symphony is suing, claiming IMS Health cost it millions in sales and negatively affected its customers, allegedly scheming to monopolize over the industry and in turn preventing Symphony from getting a hold of 80 percent of generated data by long-term care facilities. The lawsuit also indicated that IMS Health operates in most continents, maintained “exclusive relationships” with other data suppliers, and holds a history of anticompetitive behavior. Symphony claimed that IMS Health had succeeded or tried to succeed in taking over the targeting and compensation data market, the managed market data market, the integrated global data market, and the anonymous patient longitudinal data market. Due to these violations, Symphony is seeking an “injunction, lost profits, and treble damages
Full Content: Courthouse News Service
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI